Forestalling age-impaired angiogenesis and blood flow by targeting NOX Interplay of NOX1, IL-6, and SASP in propagating cell senescence

• Published in: Proceedings of the National Academy of Sciences - PNAS Vol. 118; no. 42; pp. 1 - 11
• Main Authors: Li, Yao, Kračun, Damir, Dustin, Christopher M., Massry, Mohamed El, Yuan, Shuai, Goossen, Christian J., DeVallance, Evan R., Sahoo, Sanghamitra, Hilaire, Cynthia St, Gurkar, Aditi U., Finkel, Toren, Straub, Adam C., Cifuentes-Pagano, Eugenia, Pagano, Patrick J.
• Format: Journal Article
• Language: English
• Published: United States National Academy of Sciences 19.10.2021
• Subjects: Age; Aging; Aging - physiology; Angiogenesis; Animals; Biological Sciences; Blood flow; Damage; Diabetes mellitus; DNA Damage; Down-regulation; Endothelial cells; Gene Knockdown Techniques; Humans; Hyperglycemia; Hyperglycemia - metabolism; Inflammation; Interleukin 6; Interleukin-6 - metabolism; Mice; NAD(P)H oxidase; NADPH Oxidases - antagonists & inhibitors; NADPH Oxidases - genetics; NADPH Oxidases - metabolism; Neovascularization, Physiologic - physiology; Operant conditioning; Peroxisome proliferator-activated receptors; Phenotypes; Senescence; Senescence-Associated Secretory Phenotype; Signaling; System effectiveness; Transcription; Vasodilation; senescence; endothelium; aging; NADPH oxidase; IL-6
• ISSN: 0027-8424; 1091-6490; 1091-6490
• DOI: 10.1073/pnas.2015666118

In an aging population, intense interest has shifted toward prolonging health span. Mounting evidence suggests that cellular reactive species are propagators of cell damage, inflammation, and cellular senescence. Thus, such species have emerged as putative provocateurs and targets for senolysis, and a clearer understanding of their molecular origin and regulation is of paramount importance. In an inquiry into signaling triggered by aging and proxy instigator, hyperglycemia, we show that NADPH Oxidase (NOX) drives cell DNA damage and alters nuclear envelope integrity, inflammation, tissue dysfunction, and cellular senescence in mice and humans with similar causality. Most notably, selective NOX1 inhibition rescues age-impaired blood flow and angiogenesis, vasodilation, and the endothelial cell wound response. Indeed, NOX1i delivery in vivo completely reversed age-impaired hind-limb blood flow and angiogenesis while disrupting a NOX1-IL-6 senescence-associated secretory phenotype (SASP) proinflammatory signaling loop. Relevant to its comorbidity with age, clinical samples from diabetic versus nondiabetic subjects reveal as operant this NOX1-mediated vascular senescence and inflammation in humans. On a mechanistic level, our findings support a previously unidentified role for IL-6 in this feedforward inflammatory loop and peroxisome proliferator–activated receptor gamma (PPARγ) down-regulation as inversely modulating p65-mediated NOX1 transcription. Targeting this previously unidentified NOX1-SASP signaling axis in aging is predicted to be an effective strategy for mitigating senescence in the vasculature and other organ systems.